Feifeng (Chimmy) Tao

Chimmy’s recent experience includes advising:

• The underwriters on the US$40.63 million initial public offering of American depositary shares on the NASDAQ Global Market for QuantaSing, an online learning service provider in China
• The underwriters in the secondary listing and US$1.07 billion initial public offering of Trip.com, a leading one-stop travel platform globally, on the Main Board of The Stock Exchange of Hong Kong Limited
• The underwriters on the follow-on offering of US$1.42 billion American depositary shares by Futu Holdings Limited, a financial technology platform in China, on the NASDAQ Global Market
• The underwriters on the US$140 million initial public offering of American depositary shares on the NASDAQ for Adagene Inc., a clinical stage biopharmaceutical company in China
• The underwriters on the US$2.5 billion follow-on offering of American depositary shares by XPeng Inc., a leading Chinese smart electric vehicle company
• The underwriters on the US$709 million initial public offering of American Depositary Shares on the New York Stock Exchange for Yatsen Holding Limited, the parent company of Chinese cosmetics brand Perfect Diary
• Nam Tai Property Inc. on the US$170 million private placement of its common shares with investors Kaisa Group Holdings Ltd. and a large-scale integrated financial group based in Hong Kong
• The underwriters on the US$1.7 billion initial public offering of American depository shares on the New York Stock Exchange of XPeng Inc., a leading smart electric vehicle company in China
• The underwriters on the offering of 9,500,000 American depositary shares by Futu Holdings Limited
• The underwriters on the US$130 million initial public offering of American Depositary Shares on the New York Stock Exchange of Phoenix Tree Holdings Limited (Danke, one of the largest co-living platforms in China) 
• The underwriters on the US$100 million initial public offering of American depositary shares on the NASDAQ of Futu Holdings, an online brokerage platform
• Wenzhou Kangning Hospital Co., Ltd., the largest private psychiatric healthcare group in China as measured by revenue in 2014, on its US$101 million initial public offering of H shares on the Main Board of Hong Kong Stock Exchange*
• Hydoo International Holding Limited on its US$216.4 million initial public offering on the Main Board of Hong Kong Stock Exchange*
• CITIC Securities Co. Ltd. on its US$1.81 billion initial public offering of H shares on the Main Board of Hong Kong Stock Exchange *
• CITIC Dameng Holdings Limited on its US$266 million initial public offering on the Main Board of Hong Kong Stock Exchange*
• CITIC Private Equity on its US$111 million placing and sale of shares of 3SBio Inc*
• Credit Suisse Securities (USA) LLC and Barclays Capital Inc., on the US$75 million follow-on ADS offering and US$35 million ordinary shares concurrent private placement, and up to US$100 million at-the-market ADS offering of JinkoSolar Holding Co., Ltd.*

*Matter handled prior to joining Latham